Skip to main content
. 2022 May 12;38(2):403–415. doi: 10.1007/s00467-022-05591-5

Table 2.

Mixed repeated measures model for change from baseline in total plasma oxalate (µmol/L): least squares means estimates at Week 52

Treatment group LS mean difference (Oxabact–Placebo)
LS Mean (SE) Estimate (SE) 95% CI p-value
Full analysis set
  Oxabact (n = 12) –0.788 (1.374) –3.802 (2.033) –7.829, 0.225 0.06
  Placebo (n = 8) 3.015 (1.613) - - -

CI, confidence interval; LS, Least Squares; SE, mean estimate